Ketamine Hydrochloride for depressive disorder, treatment-resistant

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Jun 2019: Trial started, NCT04216888
  2. 3 Jan 2020: Trial registered, NCT04216888

The trials

NCT04216888: Biomarkers of Response to Ketamine in Depression: MRI and Blood Assays Before and After Open Label Intranasal Ketamine

State
Completed
Phase
Phase 2 and Phase 3
People
9 taking part
Started
26 Jun 2019
Primary completion
28 Dec 2020
Arms
Open label
Results
None posted
  1. 26 Jun 2019: Trial started
  2. 3 Jan 2020: Trial registered
  3. 28 Dec 2020: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Ketalar, Ketaset, Ketamine hydrochloride infusion, Vetalar.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.